Caris Life Sciences was founded with a very simple but powerful purpose – to help improve the lives of as many people as possible. With transformative technologies, we are revolutionizing precision medicine to provide physicians and patients with the highest quality information about their health. Through tireless efforts, breakthrough molecular science and a passionate commitment to quality, we remain steadfastly focused on the most important part of our work – the patient.”
David D. Halbert
Chairman & CEO
Caris Life Sciences
Description: Chadi Nabhan, MD, MBA, FACP, Chairman of Caris Precision Oncology Alliance™, Neelima Denduluri, MD, Associate Chair of the US Oncology Breast Cancer Research Committee, Cancer Committee Chairman at Virginia Hospital Center, and Co-Director of the Virginia Cancer Specialists Research Program and Stephen Liu, MD, Associate Professor of Medicine, Director of Thoracic Oncology, Georgetown University will review and discuss key findings from the 2020 ASCO and AACR.
Date: Wednesday, August 12, 2020
Time: 3:00 – 3:45 PM CT